跳至主要内容
临床试验/CTRI/2025/09/094265
CTRI/2025/09/094265尚未招募3 期

Comparison of letrzole Vs Mifepristone as pre-treatment in first trimester medical abortion : A Randomised controlled Trial

Hamdard Institute of Medical sciences and research1 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2025年9月15日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
110
试验地点
1
主要终点
To Compare efficacy of Letrozole & Mifepristone as pretreatment in First Trimester Medical Abortions.

研究概览

简要总结

This academic study is based on the two drugs already in use in the market

Mifepristone and Letrozole

comparison between the two drugs for

1.Efficacy

2.complete evacuation  rate

3.Cost effectiveness

  1. no. of doses of misoprostol required

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)
性别
Female

入选标准

  • 1.Maternal age>18yrs.
  • 2.Women wanting medical termination of pregnancy < 12 weeks.
  • 3.Women opting for medical termination of Pregnancy.
  • 4.Who agreed to participate in the trial voluntarily with informed consents.

排除标准

  • 1.Age below 18yrs 2.Suspected Ectopic Pregnancy 3.H/O any co-morbidities(CKD, Adrenal insufficiency, Heart, Liver disease)/ H/O of any coagulatory dysfunction/ anticoagulant drugs.
  • 4.Abnormal Uterine Lesions(Fibroids, congenital malformations or intrauterine adhesions).

结局指标

主要结局

To Compare efficacy of Letrozole &amp; Mifepristone as pretreatment in First Trimester Medical Abortions.

时间窗: Comparison between the two drugs after 2 weeks of time and assessment period

次要结局

  • 1.To Compare the mean induction to abortion interval.

研究者

发起方
Hamdard Institute of Medical sciences and research
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Dr.Aanchal Singh

HAMDARD INSTITUTE OF MEDICAL SCIENCES AND RESEARCH

研究点 (1)

Loading locations...

相似试验